Ceapro Inc. — Investor Relations & Filings
Ceapro Inc. is a biotechnology company specializing in the development and commercialization of natural-based active ingredients derived primarily from oats and other renewable sources. The company utilizes proprietary extraction technology to produce high-value compounds, including Oat Beta Glucan, Oat Avenanthramides, and Oat Oil. These ingredients are engineered for applications across multiple sectors. Key markets include cosmeceuticals (for skin barrier function, hydration, and anti-aging), nutraceuticals (for cholesterol management and gut health), and pharmaceuticals (currently developing anti-inflammatory treatments). The company's unique focus is on combining the simplicity of nature with scientific innovation to deliver solutions that improve global health and wellness.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Notice.pdf | 2024-06-06 | English | |
| Material change report - English.pdf | 2024-06-06 | English | |
| News release - English.pdf | 2024-06-03 | English | |
| News release - English.pdf | 2024-02-26 | English | |
| News release - English.pdf | 2024-02-26 | English | |
| News release - English.pdf | 2024-02-23 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 30201774 | Notice.pdf | 2024-06-06 | English | ||
| 30201783 | Material change report - English.pdf | 2024-06-06 | English | ||
| 30156344 | News release - English.pdf | 2024-06-03 | English | ||
| 29581318 | News release - English.pdf | 2024-02-26 | English | ||
| 29581396 | News release - English.pdf | 2024-02-26 | English | ||
| 13721927 | News release - English.pdf | 2024-02-23 | English | ||
| 13720193 | News release - English.pdf | 2024-02-15 | English | ||
| 13720198 | News release - English.pdf | 2024-02-15 | English | ||
| 13720230 | Other material contracts - English.pdf | 2024-02-15 | English | ||
| 13720229 | Other material contracts - English.pdf | 2024-02-15 | English | ||
| 13720242 | Notice of meeting - English.pdf | 2024-02-15 | English | ||
| 13720241 | Other.pdf | 2024-02-15 | English | ||
| 13720239 | Form of proxy - French.pdf | 2024-02-15 | English | ||
| 13720238 | Form of proxy - English.pdf | 2024-02-15 | English | ||
| 13720237 | Management information circular - English.pdf | 2024-02-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Dermata Therapeutics, Inc.
Medical dermatology company developing and commercializing …
|
DRMA | US | Manufacturing |
|
Desh Rakshak Aushdhalaya Ltd.
Manufacturer of GMP-certified Ayurvedic and herbal medicine…
|
531521 | IN | Manufacturing |
|
Design Therapeutics, Inc.
Clinical-stage biopharma developing small molecule therapie…
|
DSGN | US | Manufacturing |
|
Deutsche Biotech Innovativ AG
Develops therapeutics for serious diseases using innovative…
|
DBI | DE | Manufacturing |
|
DEVA HOLDİNG A.Ş.
Develops, produces, and markets human medicines, APIs, and …
|
DEVA | ES | Manufacturing |
|
Devonian Health Group Inc
Clinical-stage botanical pharmaceutical company focused on …
|
GSD | CA | Manufacturing |
|
Devyser Diagnostics
Develops DNA testing kits for hereditary diseases, oncology…
|
DVYSR | SE | Manufacturing |
|
DexTech Medical AB
Develops drug candidates for urological oncology, focusing …
|
DEX | SE | Manufacturing |
|
Dezhan Healthcare Company Limited
Researches and produces cardiovascular chemical drugs and o…
|
000813 | CN | Manufacturing |
|
DiaMedica Therapeutics Inc.
Clinical-stage biopharma developing therapies for ischemic …
|
DMAC | US | Manufacturing |
Ceapro Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44617/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44617 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44617 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44617 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44617}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ceapro Inc. (id: 44617)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.